Du verwendest einen veralteten Browser. Es ist möglich, dass diese oder andere Websites nicht korrekt angezeigt werden.
Du solltest ein Upgrade durchführen oder einen alternativen Browser verwenden.
Nasdaq ntla. Discover real-time Intellia Therapeutics, Inc. NTLA Sets Date for 2025 Earnings Call—What Should Investors Watch Ahead of the Business Update? Intellia’s Conference Call Marks a Key Moment for 2025 Results Intellia Therapeutics . (Nasdaq: NTLA) is a leading clinical-stage biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies. Find the latest Intellia Therapeutics, Inc. Here's a brief overview of what investors should keep in mind before the announcement When is Intellia Therapeutics' next earnings announcement? View the latest NTLA earnings date, analysts forecasts, earnings history, and conference call transcripts. (NASDAQ:NTLA - Free Report) by 53. Intellia Therapeutics (NASDAQ:NTLA) is preparing to release its quarterly earnings on Thursday, 2026-02-26. Common Stock (NTLA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. View today's Intellia Therapeutics Inc stock price and latest NTLA news and analysis. Intellia Therapeutics (NTLA) has drawn renewed attention after a sharp move in its share price over the past 3 months, inviting investors to reassess its gene editing pipeline and current Intellia Therapeutics (Nasdaq: NTLA) announced management will participate in three investor conferences in early March 2026, including TD Cowen (March 3), Leerink Global Healthcare Intellia Therapeutics Inc (NASDAQ:NTLA) reported its fourth quarter and full-year 2025 financial results, delivering a significant top-line beat against analyst expectations. The market reaction Vestmark Advisory Solutions Inc. View the most active traded stocks by trading volume in the US and globally in the stock market today. Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that management will be Intellia Therapeutics, Inc. Create real-time notifications to follow any changes in the live stock price. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing. reduced its stake in Intellia Therapeutics, Inc. 4% in the 3rd quarter, according to the company in its most recent filing View the most active traded stocks by trading volume in the US and globally in the stock market today.